Key result
Alveolar soft-part sarcoma linked to a ~40% initial distant metastasis rate and early mortality.
Why the study?
The clinical and pathologic features and management challenges of alveolar soft-part sarcoma were characterized to emphasize the importance of metastasis management.
Observational (n=10)
Alveolar soft-part sarcoma has a high tendency for distant metastasis without local recurrence, emphasizing the importance of managing metastasis.
Supports metastatic surveillance in alveolar soft-part sarcoma; leaves open optimal strategies given case-report evidence.
The clinical and pathologic features of ten cases of alveolar soft-part sarcoma (ASPS) were observed in subjects aged ten to 49 years. Eight were male and two were female. The lesion involved the thigh in six cases and the adjacent bone in three. All lesions were retrospectively classified as high risk (Stage II or III of Enneking's staging system), and distant metastasis to lung or bone was noted at initial presentation in four patients. Three patients died with distant metastases at a mean time of three years seven months after diagnosis. The mean interval from initial presentation to detection of distant metastasis was nine months; and the mean interval from detection of metastasis to death was three years two months. Ultrastructural studies demonstrated typical organoid arrangement of the neoplastic cells surrounded by a basement membrane with close attachment of individual cells to the basal lamina. No local recurrence, even in cases with inadequate tumor control, and the tendency for distant metastasis demonstrated in the current series, reemphasized that management of metastasis is most important in the treatment of ASPS.
No takes yet. Share an insight, caveat, or question.
Nakashima et al. (1993) conducted an observational in Alveolar soft-part sarcoma (n=10). Alveolar soft-part sarcoma was evaluated. Alveolar soft-part sarcoma in 10 patients was associated with a high rate of distant metastasis, with 4 presenting with metastasis initially and 3 dying at a mean of 3 years 7 months post-diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: